Our prior findings demonstrated that C. officinalis promoted activation of the Keap1/Nrf2 pathway in a pancreatic β-cell line and delayed the onset of type 1 diabetes (T1D) in non-obese diabetic (NOD) mice. This evidence concerns the gene NFE2L2 and type 1 diabetes mellitus.